Dr. Matthew Milowsky, MD
Claim this profileUNC Lineberger Comprehensive Cancer Center
Area of expertise
Bladder Cancer
Matthew Milowsky, MD has run 8 trials for Bladder Cancer. Some of their research focus areas include:
Germ Cell Tumor Of The Central Nervous System
Matthew Milowsky, MD has run 2 trials for Germ Cell Tumor of the Central Nervous System. Some of their research focus areas include:
Affiliated Hospitals
UNC Lineberger Comprehensive Cancer Center
Lineberger Comprehensive Cancer Center At University Of North Carolina - Chapel Hill
Clinical Trials Matthew Milowsky, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
FX-909
for Bladder Cancer
This trial tests a new tablet called FX-909 for safety and proper dosage in patients with advanced solid tumors, especially advanced urothelial carcinoma. Doctors will closely monitor patients to understand how the drug works and its effects on the body and tumors.
Recruiting
1 award
Phase 1
More about Matthew Milowsky, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Matthew Milowsky, MD has experience with
- Cisplatin
- Gemcitabine
- Pembrolizumab
- Carboplatin
- ATLCAR.CD30 Cells
- Cyclophosphamid
Breakdown of trials Matthew Milowsky, MD has run
Bladder Cancer
Germ Cell Tumor of the Central Nervous System
Germ Cell Tumors
Transitional Cell Carcinoma
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Milowsky, MD specialize in?
Matthew Milowsky, MD focuses on Bladder Cancer and Germ Cell Tumor of the Central Nervous System. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Matthew Milowsky, MD currently recruiting for clinical trials?
Yes, Matthew Milowsky, MD is currently recruiting for 3 clinical trials in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Matthew Milowsky, MD has studied deeply?
Yes, Matthew Milowsky, MD has studied treatments such as Cisplatin, Gemcitabine, Pembrolizumab.
What is the best way to schedule an appointment with Matthew Milowsky, MD?
Apply for one of the trials that Matthew Milowsky, MD is conducting.
What is the office address of Matthew Milowsky, MD?
The office of Matthew Milowsky, MD is located at: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27514 United States. This is the address for their practice at the UNC Lineberger Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.